gsk glp 1 agonist GLP-1 receptor 2 | GCGR Agonist GLP-1 Receptor Agonists in Solid

We know that patients who are treated with GLP-1RA are much less likely to die from any cause than patients treated with DPP-IV inhibitors and sulfonylureas

rxlist.com (Byetta ) rxlist.com (Byduron ) extended release formulation Keywords Liraglutide Trade Names: Victoza & generic Pharmacology: GLP-1 analog mechanism of action is the same as exenatide Indications: an adjunct to diet and exercise to improve glycemic control in type 2 diabetes mellitus to reduce the risk of major adverse cardiovascular events (cardiovascular death, non-fatal myocardial infarction, or non-fatal stroke) in adults with type 2 diabetes mellitus and established cardiovascular disease Pharmacokinetics: once-daily injection Side Effects: Most common : nausea, diarrhea, vomiting (similar to exenatide) Black Box Warning: RISK OF THYROID C-CELL TUMORS References: Masharani U, Kroon L (2024): Pancreatic Hormones & Antidiabetic Drugs (Chapter 41)

They arent backed up by solid science and their impact on GLP-1 in humans is still unknown.

10.1186/1471-2202-13-33 BMC Neurosci

Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes

GLP-1s are generally safe, but some drugs have been withdrawn from the market due to long-term risks